Photodynamic therapy of feline cutaneous squamous cell carcinoma using a newly developed liposomal photosensitizes: Preliminary results concerning drug safety and efficacy

Journal of Veterinary Internal Medicine

Volumn 21, Issue 4, 2007, Pages 770-775

  Buchholz, Julia ^a,d   Wergin, Melanie ^a   Walt, Heinrich ^b   Gräfe, Susanna ^c   Bley, Carla Rohrer ^a   Kaser Hotz, Barbara ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^c Biolitec AG Jena   (Germany)

^d Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Cats; Liposomes; m THPC; Skin neoplasia

Indexed keywords

LIPOSOME; MESOPORPHYRIN; PHOTOSENSITIZING AGENT; TEMOPORFIN; VASCULOTROPIN A;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; CHEMISTRY; CLINICAL TRIAL; PHOTOCHEMOTHERAPY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CAT DISEASES; CATS; CHEMISTRY, PHARMACEUTICAL; LIPOSOMES; MESOPORPHYRINS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; FELIDAE;

EID: 34547743351     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2007)21[770:PTOFCS]2.0.CO;2     Document Type: Article

References (26)

1. Hausmann W. Die sensibilisierende Wirkung des Hämatoporphyrins. Biochem Z 1911;30:276.
2. Buchholz J, Walt H, Fidel J, et al. Photodynamic therapy of feline squamous cell carcinoma and various canine tumours. Kleintierpraxis 2003;48:405-418.
3. Lucroy MD, Edwards BF, Peavy GM, et al. Preclinical study in eats of the pro-photosensitizer 5-aminolevulinic acid. Am J Vet Res 1999;60:1364-1370.
4. Magne ML, Rodriguez CO, Autry SA, et al. Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer. Lasers Surg Med 1997;20:202-209.
5. Stell AJ, Dobson JM, Langmack K. Photodynamic therapy of feline superficial squamous cell carcinoma using topical 5-aminolaevulinic acid. J Small Anim Pract 2001;42:164-169.
6. Mayer S. Stratospheric ozone depletion and animal health. Vet Rec 1992;131:120-122.
7. Withrow SJ. Tumors of the skin and subcutaneous tissues. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology, 3rd ed. Philadelphia, PA: W.B. Saunders Company; 2001:233-260.
8. Lana SE, Ogilvie GK, Withrow SJ, et al. Feline cutaneous squamous cell carcinoma of the nasal planum and the pinnae: 61 cases. J Am Anim Hosp Assoc 1997;33:329-332.
9. Melzer K, Guscetti F, Rohrer Bley C, et al. Ki67 reactivity in nasal and periocular squamous cell carcinomas in cats treated with electron beam radiation therapy. J Vet Intern Med 2006;20: 676-681.
10. Théon AP, Madewell BR, Shearn VI, et al. Prognostic factors associated with radiotherapy of squamous cell carcinoma of the nasal plane in cats. J Am Vet Med Assoc 1995;206:991-996.
11. Fidel JL, Egger E, Blattmann H, et al. Proton irradiation of feline nasal planum squamous cell carcinomas using an accelerated protocol. Vet Radiol Ultrasound 2001;42:569-575.
12. Sasnouski S, Zorin V, Khludeyev I, D'Hallewin MA, Guillemin F, Bezdetnaya L. Investigation of Fosean interactions with plasma proteins. Biochimica et Biophysica Acta 2005; 1725: 394-402.
13. Campbell GA, Bartels KE, Arnold C, et al. Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat. Lasers Med Sci 2002;17:79-85.
14. Buchholz J, Kaser-Hotz B, Khan T, et al. Optimizing photodynamic therapy: In vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma. Clin Cancer Res 2005;11:7538-7544.
15. Ferrara ND-ST. The biology of vascular endothelial growth factor. Endocrine Reviews 1997;18:4-18.
16. Hyodo I, Doi T, Endo H, et al. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur J Cancer 1998;34:2041-2045.
17. Dittadi R, Meo S, Fabris F, et al. Validation of blood collection procedures for the determination of circulating vascular endothelial factor (VEGF) in different blood compartments. Int J Biol Markers 2001;16:87-96.
18. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;457-481.
19. D'Cruz AKRM, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study of 128 patients. Head Neck 2004;26:232-240.
20. Hopper CKA, Lewis H, Tan B, Putnam G. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 2004;111:138-146.
21. Wyss P, Schwarz V, Dobler-Girdziunaite D, et al. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer. Int J Cancer 2001;93:720-724.
22. Wergin MC, Roos M, Inteeworn N, et al. The influence of fractionated radiation therapy on plasma vascular endothelial growth factor (VEGF) concentration in dogs with spontaneous tumors and its impact on outcome. Radiother Oncol 2006;79:239-244.
23. Wu YSL, Chillar R, Vadgama JV. Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment. Int J Oncol 2002;20:509-516.
24. Kelleher DK, Bastian J, Thews O, et al. Enhanced effects of aminolevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours. Br J Cancer 2003;89:405-411.
25. Allman R, Cowburn P, Mason M. Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck. Br J Cancer 2000;83:655-661.
26. McCaw DL, Pope ER, Payne JT, et al. Treatment of canine oral squamous cell carcinomas with photodynamic therapy. Br J Cancer 2000;82:1297-1299. :